Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about disclosure

03 Jan 2024 Evaluate

Zydus Lifesciences has informed that the Company has received an Assessment Order of FY 2017-18 on the issue pertaining to Input Tax Credit (‘ITC’). The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..